Alcon Inc. (LON:0A0D)

London flag London · Delayed Price · Currency is GBP · Price in CHF
60.27
+0.18 (0.30%)
At close: Oct 3, 2025
0.30%
Market Cap28.30B
Revenue (ttm)7.32B
Net Income (ttm)783.18M
Shares Outn/a
EPS (ttm)1.58
PE Ratio36.14
Forward PE23.37
Dividend0.25 (0.42%)
Ex-Dividend DateMay 13, 2025
Volume1,078,628
Average Volume431,311
Open60.10
Previous Close60.08
Day's Range59.94 - 61.40
52-Week Range58.56 - 86.98
Beta0.69
RSI39.08
Earnings DateNov 11, 2025

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]

Sector Healthcare
Founded 1945
Employees 25,599
Stock Exchange London Stock Exchange
Ticker Symbol 0A0D
Full Company Profile

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD Financial Statements

News

There is no news available yet.